Harpoon Therapeutics, Inc.
HARPDelisted Mar 11, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708493
Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Harpoon Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +9 vs. Q3 2023
- Shares held
- 15.8M
- +13.9M (+744.9%) vs. Q3 2023
- Total value
- $175.5M
- +$167.9M (+2,229.2%) vs. Q3 2023
- New holders
- 16
- 14 more added
- Sold out
- 7
- 4 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HARP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 41 | $175.5M |
| Q3 2023 | 32 | $7.53M |
| Q2 2023 | 44 | $12.0M |
| Q1 2023 | 46 | $12.9M |
| Q4 2022 | 49 | $13.7M |
| Q3 2022 | 52 | $21.0M |
| Q2 2022 | 63 | $43.4M |
| Q1 2022 | 79 | $128.2M |
| Q4 2021 | 84 | $196.3M |
| Q3 2021 | 93 | $203.9M |
| Q2 2021 | 85 | $357.3M |
| Q1 2021 | 88 | $562.3M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Harpoon Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| US Bancorp | 8 | $91 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 35 | $398 | 0.00% | −348−90.9% | Reduced |
| Allworth Financial LP | 40 | $455 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 105 | $1.19K | 0.00% | +105 | New |
| Advisor Group Holdings, Inc. | 107 | $1.22K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 134 | $1.53K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 181 | $2.06K | 0.00% | +90+98.9% | Added |
| Federation des caisses Desjardins du Quebec | 200 | $2.27K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 252 | $2.87K | 0.00% | −219−46.5% | Reduced |
| UBS Group AG | 2,608 | $29.7K | 0.00% | +2,554+4,729.6% | Added |
| Bank of America Corp | 5,943 | $67.6K | 0.00% | +5,868+7,824.0% | Added |
| BIT Capital GmbH | 7,407 | $84.2K | 0.01% | +7,407 | New |
| Cubist Systematic Strategies, LLC | 10,476 | $119.1K | 0.00% | +10,476 | New |
| Caxton Corp | 13,176 | $129.3K | 0.70% | +13,176 | New |
| Charles Schwab Investment Management Inc | 11,401 | $129.6K | 0.00% | +11,401 | New |
| Renaissance Technologies LLC | 12,756 | $145.0K | 0.00% | −12,100−48.7% | Reduced |
| Northern Trust Corp | 24,080 | $273.8K | 0.00% | +24,080 | New |
| Millennium Management LLC | 25,465 | $289.5K | 0.00% | +14,790+138.5% | Added |
| Standard Life Aberdeen plc | 25,991 | $295.5K | 0.00% | +25,991 | New |
| Two Sigma Investments, LP | 27,042 | $307.5K | 0.00% | +27,042 | New |
| Citigroup Inc | 39,222 | $446.0K | 0.00% | +39,222 | New |
| Goldman Sachs Group Inc | 48,948 | $556.5K | 0.00% | +48,948 | New |
| Kennedy Capital Management, Inc. | 52,160 | $593.1K | 0.01% | −827−1.6% | Reduced |
| Geode Capital Management, LLC | 149,262 | $1.70M | 0.00% | +124,349+499.1% | Added |
| Lion Point Capital, LP | 228,900 | $2.60M | 2.32% | +146,442+177.6% | Added |
| BlackRock Inc. | 249,834 | $2.84M | 0.00% | +212,895+576.3% | Added |
| Sio Capital Management, LLC | 297,936 | $3.39M | 0.87% | +129,919+77.3% | Added |
| Adage Capital Partners GP, L.L.C. | 300,000 | $3.41M | 0.01% | +300,000 | New |
| MPM Asset Management LLC | 313,136 | $3.56M | 1.75% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 319,670 | $3.63M | 0.85% | 00.0% | Unchanged |
| Ally Bridge Group (NY) LLC | 428,400 | $4.87M | 3.51% | +428,400 | New |
| Citadel Advisors LLC | 685,000 | $7.79M | 0.01% | +636,244+1,305.0% | Added |
| Blackstone Group Inc. | 815,000 | $9.27M | 0.04% | +815,000 | New |
| Soleus Capital Management, L.P. | 820,638 | $9.33M | 1.04% | +820,638 | New |
| Vanguard Group Inc | 880,017 | $10.0M | 0.00% | +766,655+676.3% | Added |
| Artal Group S.A. | 1,304,127 | $14.8M | 0.51% | +1,204,127+1,204.1% | Added |
| Franklin Resources Inc | 1,492,368 | $17.0M | 0.01% | +1,360,041+1,027.8% | Added |
| Ra Capital Management, L.P. | 1,500,000 | $17.1M | 0.27% | +1,500,000 | New |
| Commodore Capital LP | 1,500,000 | $17.1M | 1.49% | +1,500,000 | New |
| New Leaf Venture Partners, L.L.C. | 1,859,168 | $21.1M | 17.03% | +1,543,500+489.0% | Added |
| Cormorant Asset Management, LP | 2,349,060 | $22.6M | 1.08% | +2,295,000+4,245.3% | Added |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −62,121−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −7,670−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −706−100.0% | Sold out |
| Beaird Harris Wealth Management, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Hantz Financial Services, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |